Quantcast
War On Superbugs Spearheaded By British PM David Cameron

War On Superbugs Spearheaded By British PM David Cameron

Brett Smith for redOrbit.com - Your Universe Online In the latest development in the fight against antibiotic-resistant bacteria, British Prime Minister David Cameron announced on Wednesday that former Goldman Sachs chief economist Jim O'Neill...

Latest Pharmaceuticals policy Stories

2014-07-11 16:23:31

DUBLIN, July 11, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Doxylamine Succinate and Pyridoxine Hydrochloride Delayed-release tablets, 10 mg/10 mg. Actavis' ANDA product is a generic version of Duchesnay Inc.'s Diclegis(®), which is indicated for the treatment of nausea and vomiting of pregnancy in women who do not respond to...

2014-07-10 16:25:16

SACRAMENTO, Calif., July 10, 2014 /PRNewswire-USNewswire/ -- The Congress of California Seniors, representing organizations serving hundreds of thousands of Californians, announced its endorsement of Proposition 46 today, joining proponent Bob Pack and a broad coalition of consumer groups, health care professionals, and victims of medical negligence and prescription drug abuse. "For four decades, the justice system has discriminated against California's seniors when they try to hold...

2014-07-09 23:14:43

Family-owned business defined by sustainable manufacturing practices and a culture of giving back finds kindred alliance in Natural Partners. Scottsdale, AZ (PRWEB) July 09, 2014 Natural Partners, a leading provider of nutraceutical grade supplements to integrative healthcare practitioners has entered a distributive partnership with Hevert USA, a company based in Germany forging a new presence in the United States. Hevert, a 3rd generation family-owned business, develops hundreds of...

2014-07-08 23:08:34

Great Point Partners announces a growth recapitalization of Softbox Systems, Ltd. (“Softbox”), a leading provider of temperature controlled packaging (“TCP”) solutions for the biotechnology and pharmaceutical industries. GREENWICH, CT (PRWEB) July 08, 2014 Great Point Partners, a Greenwich-based health care investment firm, today announced a growth recapitalization of Softbox Systems, Ltd. (“Softbox”). Softbox is a leading provider of temperature controlled packaging...

2014-07-08 23:08:23

ReportsnReports.com adds “PharmaSphere: Regulatory Frameworks and Product Pipelines in the Global Biosimilars Market” to its store. Lucrative Biosimilars Space to Erode Biologics Market from 2019. Dallas, Texas (PRWEB) July 08, 2014 The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking the overall biologics market value from $162 billion in...

2014-07-08 23:05:22

Controlled Substance E-Prescribing Legal in 49 States and the District of Columbia Rockville, MD (PRWEB) July 08, 2014 DrFirst, a leading provider of healthcare IT solutions designed to improve clinical outcomes for patients, announced today that there are now over 28,000 pharmacies nationwide that accept electronically transmitted prescriptions for controlled substances, representing 41 percent of all retail pharmacies in the United States. A number of factors are driving the growth...

2014-07-08 23:01:29

Good Manufacturing Practices in Pharmaceutical and Biotech fields goes a long way in saving millions of lives worldwide in providing safe and affordable therapeutic solutions to various dreadful diseases. OMICS Group’s 3rd International Summit on GMP, GCP & Quality Control, held on September 25-26, 2014, in Valencia, Spain attains significance at this juncture as it is going to address many valid points. Los Angeles, CA (PRWEB) July 08, 2014 GMP Summit -2014 is going to discuss...

2014-07-08 16:25:34

DUBLIN, July 8, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Dalfampridine Extended-release Tablets, 10 mg. Actavis' ANDA product is a generic version of Acorda Therapeutics' Ampyra(®), which is indicated as a treatment to improve walking in patients with multiple sclerosis. Acorda Therapeutics, Inc. filed suit against Actavis on...

2014-07-08 08:31:18

Anticipated FDA action set for October 2014 STAMFORD, Conn., July 8, 2014 /PRNewswire/ -- Purdue Pharma L.P. announced that the U.S. Food & Drug Administration (FDA) has granted Priority Review designation for the company's once-daily, single-entity hydrocodone bitartrate tablet (HYD). This investigational pain medication was formulated to incorporate abuse-deterrent properties designed to make the product more difficult to manipulate for the purpose of misuse or abuse by...

2014-07-07 08:28:53

BEIJING, July 7, 2014 /PRNewswire/ -- Yabao Pharmaceutical Co, Inc. (Shanghai Stock Exchange 600351), a leading pharmaceutical company in China, today announced a strategic partnership with Eli Lilly and Company to co-develop Lilly's leading glucokinase activator (GKA), LY2608204. Lilly's GKA has completed Phase 1 studies in the US in addition to extensive pre-clinical development. Diabetes is a disease of great unmet need in China and worldwide. Glucokinase activators have the...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.